13 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

  • RTI Surgical Hldgs, Inc. RTIX stock surged 92.0% to $5.30 during Tuesday's pre-market session.
  • Adaptimmune Therapeutics, Inc. ADAP shares surged 33.1% to $5.31.
  • La Jolla Pharmaceutical, Inc. LJPC shares rose 12.3% to $7.86. According to the most recent rating by H.C. Wainwright, on November 26, the current rating is at Neutral.
  • Acasti Pharma, Inc. ACST stock increased by 5.4% to $0.80. The most recent rating by B. Riley FBR, on January 13, is at Neutral, with a price target of $2.00.
  • Aurora Cannabis, Inc. ACB shares increased by 3.8% to $1.76. The most recent rating by Piper Sandler, on January 10, is at Underweight, with a price target of $1.00.
  • NantKwest, Inc. NK shares rose 2.9% to $7.00.
  • Aphria, Inc. APHA shares surged 2.8% to $5.57. According to the most recent rating by B of A Securities, on January 13, the current rating is at Neutral.
  • Canopy Growth, Inc. CGC shares rose 2.3% to $23.65. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
  • Cronos Group, Inc. CRON stock increased by 2.3% to $7.68. The most recent rating by Bank of America, on November 13, is at Buy, with a price target of $15.00.
  • Tilray, Inc. TLRY stock increased by 1.7% to $17.66. The most recent rating by B of A Securities, on January 13, is at Neutral, with a price target of $18.00.

 

Losers

  • Dare Bioscience, Inc. DARE stock decreased by 9.7% to $1.49 during Tuesday's pre-market session.
  • AbbVie, Inc. ABBV shares plummeted 1.1% to $87.55. The most recent rating by Cowen & Co., on December 26, is at Outperform, with a price target of $98.00.
  • Genmab, Inc. GMAB shares plummeted 1.1% to $22.41. The most recent rating by SunTrust Robinson Humphrey, on January 13, is at Buy, with a price target of $28.00.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!